Monica L Zepeda PhD

Monica L Zepeda PhD has extensive work experience in the biotech and pharmaceutical industry. Monica L is currently the VP Program and Alliance Management at Avidity Biosciences, where they are involved in the development of oligonucleotide-based therapies. Prior to this, they held the position of VP Alliance and Global Operations at F1 Oncology/EXUMA Biotech, where they focused on advancing CAR-T immune therapy for solid tumors.

Before joining F1 Oncology/EXUMA Biotech, Zepeda worked at Halozyme Therapeutics, Inc. for over a decade. Monica L started as an Associate Director in Pre-Clinical, Drug Delivery and progressed to become an Executive Director in Alliance and Program Management. In this role, they led strategic alliances with large pharmaceutical companies like Hoffman La Roche Pharmaceutical, Lilly, and Pfizer Inc. Zepeda played a crucial role in the development and commercialization of several drugs, including Herceptin SC and MabThera SC, and was responsible for ensuring milestone payment realization for partnership activities.

Zepeda also gained experience as a Consultant and Vice President at Remora Pharmaceuticals and as a Principal Scientist at Schering-Plough Research Institute (Merck). In these roles, they led research and development projects, established translational animal models, conducted in vitro and in vivo experimentation, and played a key role in the evaluation and recommendation of drug candidates.

Monica L'searlier experience includes positions as a Senior Scientist at Schering-Plough Research Institute and as a Research Scientist at Hologic (formerly Gen-Probe). Zepeda's career started with their role as a Graduate Student at the University of Michigan, where they conducted research on the pathophysiology of cystic fibrosis.

Throughout their career, Zepeda has demonstrated expertise in alliance management, program leadership, preclinical development, drug delivery, and scientific team leadership. Monica L has contributed to the successful development and commercialization of various pharmaceutical products and has established a track record of meeting program goals and achieving milestones.

Monica L Zepeda, PhD, has an extensive education background. Monica L pursued their PhD in Cellular and Molecular Engineering from the University of Michigan, where they enrolled in 1991 and completed their studies in 1996. Prior to that, they obtained a BA in Mammalian Physiology and Bioethics from UC San Diego, attending the institution between 1981 and 1986. Additionally, in 2017, they received a certification in Alliance Management from the Association Strategic Alliance Professionals.